Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Doge Jones Industrial Average Partners with Indexify to Launch First Functional Memecoin Index
-
ViWo Starts Social Media Revolution as VCoin Presale Goes Live
-
SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
-
Fairstead and Partners Close on $120 Million Ground-Up Transformation of Historic ‘Samuel Madden Homes’ Public Housing Community in Alexandria, Virginia
-
180 Degree Capital Corp. Issues Q1 2025 Shareholder Letter
-
Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%)
-
RedCloud Reports Full Year 2024 Results
-
Nuvini Group Announces Participation in the Sidoti Micro-Cap Investor Conference
-
Vertex Named a Finalist for 2025 SAP® Pinnacle Award in the SAP Store Category
-
Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders
-
Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the Fourth Fiscal Quarter and Provides April Net Asset Value Update
-
Alignment Health Plan Recognized as One of Two Medicare Advantage Prescription Drug Plans in the U.S. for Excellence in Pharmacy Quality
-
Medera Showcased Positive Interim Data From First-in-Human Gene Therapy Trial for HFpEF in Late-Breaking Presentation at Heart Failure 2025 Congress
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Recludix Pharma Presents Data Demonstrating Potent Efficacy and High Selectivity of a STAT6 Inhibitor in Preclinical Asthma Model
-
TORRAS Redefines the iPhone Case Market with Ostand, OAir, and OFitness Series — A Fusion of Design, Durability, and Intelligent Functionality
-
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
-
SISCAPA and Biognosys Announce Strategic Collaboration to Deliver End-to-End High-Sensitivity Targeted Protein Quantification Solutions
-
JDE Peet’s share buyback periodic update May 19, 2025
-
Combining EVP roles of Human Health Biosolutions and Strategy & Integration
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ASML reports transactions under its current share buyback program
-
BIO-key and Cloud Distribution Co. Partner to Expand IAM and Biometric Security Solutions Across the Middle East
-
Porsche Cars North America’s Ayesha Coker recognized among 100 leading women in the North American auto industry
-
Transactions under Novonesis’ share buyback program
-
Agenda
-
TopBuild Extends and Upsizes Senior Secured Credit Facilities
-
IES Holdings, Inc. Appoints Matthew Simmes to Succeed Jeffrey Gendell as Chief Executive Officer
-
AMD Announces Agreement to Divest ZT Systems Data Center Infrastructure Manufacturing Business to Sanmina
-
Renowned IO Economist Professor B. Douglas Bernheim Affiliates with Compass Lexecon
-
Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)
-
Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to
-
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
-
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
-
Director/PDMR Shareholding
-
Auction result of Treasury Bills - RIKV 25 0820 - RIKV 25 1119
-
Form 8.3 - Primary Health Properties
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
Gilat Reports First Quarter 2025 Results
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BAKKAVOR GROUP PLC - Ordinary Shares
-
Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System
-
FEMSA Announces Accelerated Share Repurchase Agreement
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AVIVA PLC - Ordinary Shares
-
LIS Technologies Inc. to Unleash American Energy: Closing of Third Consecutive Oversubscribed Funding Round of $11.93M and Totaling Over $47M to Rebirth the Only United States Origin and Patented Tech
-
Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness
-
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
-
Medical Learning Institute Inc Launches reelCE™, a Social-First Approach to Earning Continuing Education Credit
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ASSURA PLC - Ordinary Shares
-
Mobilicom Provides First Quarter 2025 Update and Financial Highlights
-
XORTX Announces USD $3 Million Offering

